Suchergebnisse - "Menges, Craig W"

PubPharm (30)

1

Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling

enthalten in: Molecular cancer research : MCR | 2022

von Sementino, E. | Kadariya, Y. | Cheung, M. | +10

2

Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Tan, Y. | Sementino, E. | Cheung, M. | +12

3

Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Malignant Mesothelioma

enthalten in: bioRxiv.org | 2020

von Sementino, E. | Kadariya, Y. | Cheung, M. | +10

4

Challenging Global Waste Management - Bioremediation to Detoxify Asbestos

enthalten in: Frontiers in environmental science | 2020

von Wallis, S. | Emmett, E. | Hardy, R. | +9

5

Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models

enthalten in: Cancer research | 2019

von Kukuyan, A. | Sementino, E. | Kadariya, Y. | +9

6

Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas

enthalten in: Journal of cellular physiology | 2018

von Sementino, E. | Menges, C. | Kadariya, Y. | +8

7

Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas

enthalten in: Journal of Cellular Physiology | 2018

von Sementino, E. | Menges, C. | Kadariya, Y. | +8

8

Haploinsufficiency in tumor predisposition syndromes : altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation

enthalten in: Oncotarget | 2017

von Peri, S. | Caretti, E. | Tricarico, R. | +23

9

Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma

enthalten in: Cancer prevention research (Philadelphia, Pa.) | 2016

von Kadariya, Y. | Menges, C. | Talarchek, J. | +8

10

Bap1 Is a Bona Fide Tumor Suppressor : Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations

enthalten in: Cancer research | 2016

von Kadariya, Y. | Cheung, M. | Xu, J. | +7